Nephros, Inc. (NEPH) is a Healthcare stock trading at $3.17 (as of 2026-06-18), with a market capitalization of $39.42M and a trailing P/E of 45.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Nephros, Inc. develops and sells water-related products for medical and commercial uses, including ultrafiltration systems used in dialysis and healthcare settings, and real-time water testing systems for assessing waterborne pathogens. It also provides renal medical device products for patients with kidney disease and water filtration solutions for food service, hospitality, convenience stores, and health care markets.